Pharmaceuticals

Adult Vaccines Market Future Trends Influencing Growth Through 2030

April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Adult Vaccines Market In 2026, And How Will Its Value Evolve By 2030?

The adult vaccines market size has experienced significant growth in recent years. It is projected to expand from $24.21 billion in 2025 to $26.34 billion in 2026, showing a compound annual growth rate (CAGR) of 8.8%. The historical growth can be attributed to several factors including the rising prevalence of infectious diseases, government immunization initiatives, the development of novel vaccines, an increasing geriatric population, and the expansion of healthcare infrastructure.

The adult vaccines market is projected for significant expansion in the coming years, predicted to reach $37.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This anticipated growth is driven by several factors, including advancements in mRNA and recombinant vaccine technologies, increased investment in adult immunization initiatives, the expansion of cold chain logistics, growing awareness of diseases preventable by vaccines, and partnerships between pharmaceutical and biotechnology firms. Key trends during this period are expected to involve heightened awareness of adult vaccination, broader immunization programs, the creation of combination vaccines, an increase in vaccines for chronic disease management, and a surging demand for travel and occupational-specific vaccines.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

Which Major Drivers Are Influencing The Expansion Of The Adult Vaccines Market?

Rising healthcare spending fueled the expansion of the adult vaccine market. This expenditure encompasses the overall cost of medical services provided to a populace. Higher healthcare outlays frequently result in more robust financing for medical research and innovation. By investing in vaccination initiatives and improving vaccine accessibility, healthcare systems can alleviate the impact of avoidable illnesses and enhance general public well-being. Furthermore, immunizing adults can generate substantial cost efficiencies by lowering the demand for healthcare services and the necessity for costly therapies. As an illustration, figures from November 2023, reported by the Canadian Institute for Health Information, a health firm based in Canada, indicate that Canada’s overall health spending in 2023 is estimated to reach $344 billion, marking an increase exceeding $9 billion from the previous year, 2022. Consequently, this rise in healthcare expenditure positively influenced the expansion of the adult vaccine market.

Which Segments Define The Adult Vaccines Market Segment Structure?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Which Trends Are Guiding The Direction Of The Adult Vaccines Market?

Leading companies in the adult vaccines market are concentrating on developing advanced technologies, such as mRNA-based vaccines, to create swift and accurate immune responses, thereby meeting the growing requirement for adult protection against respiratory conditions. An mRNA vaccine functions by encasing messenger RNA within lipid nanoparticles, which then instruct human cells to produce specific viral proteins, triggering an immune response without the use of live or attenuated viruses. For example, in May 2024, Moderna, a US-based biotechnology company, obtained FDA approval for mRESVI, an mRNA respiratory syncytial virus (RSV) vaccine designed for adults aged 60 years and older. This vaccine encodes the prefusion F glycoprotein of RSV and is administered via single-dose, pre-filled syringes, which promotes neutralizing antibody production, offers improved safety and efficacy over conventional inactivated or live-attenuated vaccines, and expands the choices available for adult immunization.

Who Are The Established Players Within The Adult Vaccines Market?

Major companies operating in the adult vaccines market are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Get The Full Adult Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Region Holds The Highest Market Share In The Adult Vaccines Market?

North America was the largest region in the adult vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Adult Vaccines Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Browse Through More Reports Similar to the Global Adult Vaccines Market 2026, By The Business Research Company

Adult Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Pediatric Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795